| Product Code: ETC7917188 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Oncology NGS Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Oncology NGS Market - Industry Life Cycle |
3.4 Latvia Oncology NGS Market - Porter's Five Forces |
3.5 Latvia Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Latvia Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Latvia Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Latvia Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Latvia Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Latvia |
4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology for oncology applications |
4.2.3 Technological advancements in NGS platforms for oncology research |
4.3 Market Restraints |
4.3.1 High costs associated with NGS technology and testing |
4.3.2 Limited expertise and infrastructure for NGS in oncology in Latvia |
5 Latvia Oncology NGS Market Trends |
6 Latvia Oncology NGS Market, By Types |
6.1 Latvia Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Latvia Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Latvia Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Latvia Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Latvia Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Latvia Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Latvia Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Latvia Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Latvia Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Latvia Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Latvia Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Latvia Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Latvia Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Latvia Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Latvia Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Latvia Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Latvia Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Latvia Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Latvia Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Latvia Oncology NGS Market Import-Export Trade Statistics |
7.1 Latvia Oncology NGS Market Export to Major Countries |
7.2 Latvia Oncology NGS Market Imports from Major Countries |
8 Latvia Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing in oncology |
8.2 Number of oncology research studies utilizing NGS in Latvia |
8.3 Rate of adoption of NGS technology by oncologists in Latvia |
9 Latvia Oncology NGS Market - Opportunity Assessment |
9.1 Latvia Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Latvia Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Latvia Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Latvia Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Latvia Oncology NGS Market - Competitive Landscape |
10.1 Latvia Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Latvia Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here